Photanol

Photanol was a Dutch biotechnology company that developed a platform technology using engineered cyanobacteria to convert CO2 directly into renewable carbon compounds. By utilizing sunlight in specialized photobioreactors, the company aimed to replace fossil-based raw materials with circular, CO2-derived feedstock. Its patented technology allowed for the engineering of various biological production routes, enabling the creation of diverse industrial chemicals including ingredients for beauty, healthcare, and pharmaceutical products, as well as polymers and potential fuels. The process was designed to operate without the need for arable land, offering a carbon-neutral alternative to traditional energy-intensive chemical manufacturing.

The company focused on transforming the chemical industry toward a circular and responsible model to reduce industrial carbon footprints. Through collaborations with industry partners and academic institutions, Photanol reached the pilot scale, operating facilities in Amsterdam and Delfzijl to demonstrate commercial viability. Despite confirming the effectiveness of its technology and preparing for large-scale production, the company faced significant financial challenges following the withdrawal of a key industrial partner in late 2024. Consequently, Photanol filed for bankruptcy and ceased operations in early 2025, though efforts were initiated to explore the preservation and future use of its technology platform.